|
1
|
Saigal CS, Joyce G and Timilsina AR;
Urologic Diseases in America Project: Direct and indirect costs of
nephrolithiasis in an employed population: opportunity for disease
management? Kidney Int. 68:1808–1814. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alexander RT, Hemmelgarn BR, Wiebe N,
Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC and Tonelli
M: Alberta Kidney Disease Network: Kidney stones and kidney
function loss: A cohort study. BMJ. 345:e52872012. View Article : Google Scholar
|
|
3
|
Shoag J, Halpern J, Goldfarb DS and Eisner
BH: Goldfarb, Brian H. Eisner. Risk of chronic and end-stage kidney
disease in people with nephrolithiasis. J Urol. 192:1440–1445.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taylor EN, Stampfer MJ and Curhan GC:
Obesity, weight gain and the risk of kidney stones. JAMA.
293:455–462. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang HS, Ma MC and Chen J: Low-vitamin E
diet exacerbates calcium oxalate crystal formation via enhanced
oxidative stress in rat hyperoxaluric kidney. Am J Physiol Renal
Physiol. 296:F34–F45. 2009. View Article : Google Scholar
|
|
6
|
Ma MC, Chen YS and Huang HS: Erythrocyte
oxidative stress in patients with calcium oxalate stones correlates
with stone size and renal tubular damage. Urology. 83:510e9–e17.
2014. View Article : Google Scholar
|
|
7
|
Chen S and El-Dahr SS: Histone
deacetylases in kidney development: Implications for disease and
therapy. Pediatr Nephrol. 28:689–698. 2013. View Article : Google Scholar
|
|
8
|
Marumo T, Hishikawa K, Yoshikawa M,
Hirahashi J, Kawa-chi S and Fujita T: Histone deacetylase modulates
the proinflammatory and-fibrotic changes in tubulointerstitial
injury. Am J Physiol Renal Physiol. 298:F133–F141. 2010. View Article : Google Scholar
|
|
9
|
Advani A, Huang Q, Thai K, Advani SL,
White KE, Kelly DJ, Yuen DA, Connelly KA, Marsden PA and Gilbert
RE: Long-term administration of the histone Deacetylase Inhibitor
vorinostat attenuates renal injury in experimental diabetes through
an endothelial nitric oxide synthase-dependent mechanism. Am J
Pathol. 178:2205–2214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang B, Zhu X, Kim Y, Li J, Huang S,
Saleem S, Li RC, Xu Y, Dore S and Cao W: Histone deacetylase
inhibition activates transcription factor Nrf2 and protects against
cerebral ischemic damage. Free Radic Biol Med. 52:928–936. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okada A, Nomura S, Higashibata Y, Hirose
M, Gao B, Yoshimura M, Itoh Y, Yasui T, Tozawa K and Kohri K:
Successful formation of calcium oxalate crystal deposition in mouse
kidney by intraabdominal glyoxylate injection. Urological research.
35:89–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonventre JV: Kidney injury molecule-1
(KIM-1): An urinary biomarker and much more. Nephrol Dial
Transplant. 24:1–4. 2009. View Article : Google Scholar
|
|
13
|
Han WK, Waikar SS, Johnson A, Betensky RA,
Dent CL, Devarajan P and Bonventre JV: Urinary biomarkers in the
early diagnosis of acute kidney injury. Kidney Int. 73:863–869.
2008. View Article : Google Scholar :
|
|
14
|
Cho ST, Jung SI, Myung SC and Kim TH:
Correlation of metabolic syndrome with urinary stone composition.
Int J Urol. 20:208–213. 2013. View Article : Google Scholar
|
|
15
|
Oda E: Medical check-up center, tachikawa
medical center: Overweight and high-sensitivity C-reactive protein
are weakly associated with kidney stone formation in Japanese men.
Int J Urol. 21:1005–1011. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moriyama MT, Suga K, Miyazawa K, Tanaka T,
Higashioka M, Noda K, Oka M, Tanaka M and Suzuki K: Inhibitions of
urinary oxidative stress and renal calcium level by an extract of
Quercus salicinaBlume/Quercus stenophyllaMakino in a rat calcium
oxalate urolithiasis model. Int J Urol. 16:397–401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirose M, Yasui T, Okada A, et al: Renal
tubular epithelial cell injury and oxidative stress induce calcium
oxalate crystal formation in mouse kidney. Int J Urol, 2010.
17:83–92. 2010.
|
|
18
|
Khan SR, Joshi S, Wang W and Peck AB:
Regulation of macromolecular modulators of urinary formation by
reactive oxygen species: Transcriptional study in an animal model
of hyperoxaluria. Am J Physiol Renal Physiol. 306:F1285–F1295.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanlaya R, Fong-Ngern K and Thongboonkerd
V: Cellular adaptive response of distal renal tubular cells to
high-oxalate environment highlights surface alpha-enolase as the
enhancer of calcium oxalate monohydrate crystal adhesion. J
Proteomics. 80:55–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Y, Sakatsume M, Nishi S, Narita I,
Arakawa M and Gejyo F: Expression, roles, receptors and regulation
of osteopontin in the kidney. Kidney Int. 60:1645–1657. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brown LF, Berse B, Van de Water L,
Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF and
Senger DR: Expression and distribution of osteopontin in human
tissues: Widespread association with luminal epithelial surfaces.
Mol Biol Cell. 3:1169–1180. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ullrich O, Mann K, Haase W and Koch-Brandt
C: Biosynthesis and secretion of an osteopontin-related 20-kDa
polypeptide in the Madin-Darby canine kidney cell line. J Biol
Chem. 266:3518–3525. 1991.PubMed/NCBI
|
|
23
|
Asselman M, Verhulst A, De Broe ME and
Verkoelen CF: Calcium oxalate crystal adherence to hyaluronan-,
osteopontin- and CD44-expressing injured/regenerating tubular
epithelial cells in rat kidneys. J Am Soc Nephrol. 14:3155–3166.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsuji H, Shimizu N, Nozawa M, Umekawa T,
Yoshimura K, De Velasco MA, Uemura H and Khan SR: Osteopontin
knockdown in the kidneys of hyperoxaluric rats leads to reduction
in renal calcium oxalate crystal deposition. Urolithiasis.
42:195–202. 2014.PubMed/NCBI
|
|
25
|
Fujii Y, Okada A, Yasu T, Niimi K,
Hamamoto S, Hirose M, Kubota Y, Tozawa K, Hayashi Y and Kohri K:
Effect of adiponectin on kidney crystal formation in metabolic
syndrome model mice via inhibition of inflammation and apoptosis.
PLoS One. 8:e613432013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pang M, Kothapally J, Mao H, Tolbert E,
Ponnusamy M, Chin YE and Zhuang S: Inhibition of histone
deacetylase activity attenuates renal fibroblast activation and
interstitial fibrosis in obstructive nephropathy. Am J Physiol
Renal Physiol. 297:F996–F1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Khaskhali MH, Byer KJ and Khan SR: The
effect of calcium on calcium oxalate monohydrate crystal-induced
renal epithelial injury. Urol Res. 37:1–6. 2009. View Article : Google Scholar
|
|
28
|
Niimi K, Yasui T, Okada A, Hirose Y,
Kubota Y, Umemoto Y, Kawai N, Tozawa K and Kohri K: Novel effect of
the inhibitor of mitochondrial cyclophilin D activation,
N-methyl-4-isoleucine cyclosporin, on renalcalcium crystallization.
Int J Urol. 21:707–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
